Hikma Pharmaceuticals Investor Relations Material
Latest events
H2 2024 Q&A
Hikma Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Hikma Pharmaceuticals PLC
Access all reports
Hikma Pharmaceuticals PLC is a multinational pharmaceutical company specializing in the development, manufacturing, and distribution of branded, generic, and injectable medicines. The company serves a wide range of therapeutic areas, including cardiovascular, oncology, pain management, and respiratory diseases. Hikma provides high-quality, affordable medications to hospitals, pharmacies, and wholesalers in global markets. The company is headquartered in London, United Kingdom, and its shares are listed on the LSE (London Stock Exchange).
Key slides for Hikma Pharmaceuticals PLC
H2 2024
Hikma Pharmaceuticals PLC
43rd Annual J.P. Morgan Healthcare Conference 2025
Hikma Pharmaceuticals PLC
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
HIK
Country
🇬🇧 United Kingdom